TR201819197A2 - Bi̇r multi̇pl skleroz ajani ve en az bi̇r anti̇-epi̇lepti̇k ajan i̇çeren bi̇r kombi̇nasyon - Google Patents

Bi̇r multi̇pl skleroz ajani ve en az bi̇r anti̇-epi̇lepti̇k ajan i̇çeren bi̇r kombi̇nasyon

Info

Publication number
TR201819197A2
TR201819197A2 TR2018/19197A TR201819197A TR201819197A2 TR 201819197 A2 TR201819197 A2 TR 201819197A2 TR 2018/19197 A TR2018/19197 A TR 2018/19197A TR 201819197 A TR201819197 A TR 201819197A TR 201819197 A2 TR201819197 A2 TR 201819197A2
Authority
TR
Turkey
Prior art keywords
agent
multiple sclerosis
combination
epileptic
sclerosis agent
Prior art date
Application number
TR2018/19197A
Other languages
English (en)
Inventor
Toksöz Zafer
Toksöz Ahmet
Original Assignee
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi filed Critical Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority to TR2018/19197A priority Critical patent/TR201819197A2/tr
Priority to PCT/TR2019/050958 priority patent/WO2020122838A2/en
Priority to EP19897521.1A priority patent/EP3893866A4/en
Publication of TR201819197A2 publication Critical patent/TR201819197A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Mevcut buluş, bir multipl skleroz ajanı ve en az bir anti-epileptik 5 ajanı içeren farmasötik bir kombinasyon ile ilgilidir, burada multipl skleroz ajanı, teriflunomid veya fampiridindir.
TR2018/19197A 2018-12-12 2018-12-12 Bi̇r multi̇pl skleroz ajani ve en az bi̇r anti̇-epi̇lepti̇k ajan i̇çeren bi̇r kombi̇nasyon TR201819197A2 (tr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
TR2018/19197A TR201819197A2 (tr) 2018-12-12 2018-12-12 Bi̇r multi̇pl skleroz ajani ve en az bi̇r anti̇-epi̇lepti̇k ajan i̇çeren bi̇r kombi̇nasyon
PCT/TR2019/050958 WO2020122838A2 (en) 2018-12-12 2019-11-15 A combination comprising a multiple sclerosis agent and at least one anti-epileptic agent
EP19897521.1A EP3893866A4 (en) 2018-12-12 2019-11-15 COMBINATION WITH AN ANTI-MULTIPLE SCLEROSIS AGENT AND AT LEAST ONE ANTI-PILEPTIC

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2018/19197A TR201819197A2 (tr) 2018-12-12 2018-12-12 Bi̇r multi̇pl skleroz ajani ve en az bi̇r anti̇-epi̇lepti̇k ajan i̇çeren bi̇r kombi̇nasyon

Publications (1)

Publication Number Publication Date
TR201819197A2 true TR201819197A2 (tr) 2020-06-22

Family

ID=71076152

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2018/19197A TR201819197A2 (tr) 2018-12-12 2018-12-12 Bi̇r multi̇pl skleroz ajani ve en az bi̇r anti̇-epi̇lepti̇k ajan i̇çeren bi̇r kombi̇nasyon

Country Status (3)

Country Link
EP (1) EP3893866A4 (tr)
TR (1) TR201819197A2 (tr)
WO (1) WO2020122838A2 (tr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240148693A1 (en) * 2021-03-17 2024-05-09 Changsha Jingyi Pharmaceutical Technology Co., Ltd Composition, preparation method therefor, and use thereof
CN114732797B (zh) * 2022-03-31 2023-03-17 海南钧华医疗科技有限公司 一种加巴喷丁和普瑞巴林复方胶囊及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200908957A (en) * 2007-06-15 2009-03-01 Xenoport Inc Use of prodrugs of GABA analogs, antispasticity agents, and prodrugs of GABAB receptor agonists for treating spasticity
CA2721148A1 (en) * 2008-04-11 2009-10-15 Epiphany Biosciences, Inc. Treatment and/or prevention of multiple sclerosis
US11026978B2 (en) * 2016-10-11 2021-06-08 Finch Therapeutics Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
PL3534904T3 (pl) * 2016-11-07 2022-07-18 Metriopharm Ag Zastosowanie 5-amino-2,3-dihydro-1,4-ftalazynodionu w leczeniu przewlekłego postępującego stwardnienia rozsianego

Also Published As

Publication number Publication date
EP3893866A4 (en) 2022-08-03
WO2020122838A3 (en) 2020-08-13
EP3893866A2 (en) 2021-10-20
WO2020122838A2 (en) 2020-06-18

Similar Documents

Publication Publication Date Title
GEP20237506B (en) Pcsk9 antagonist compounds
TR201819197A2 (tr) Bi̇r multi̇pl skleroz ajani ve en az bi̇r anti̇-epi̇lepti̇k ajan i̇çeren bi̇r kombi̇nasyon
ECSP21053104A (es) Moduladores de la expresión de hsd17b13
PH12019502110A1 (en) Pharmaceutical combination comprising ponesimod
PH12020552158A1 (en) Combination of poziotinib with cytotoxic agent and/or other molecularly targeted agent and use thereof
TR201720406A2 (tr) Bi̇r i̇skelet kasi gevşeti̇ci̇si̇ ve bi̇r multi̇pl skleroz tedavi̇ edi̇ci̇ ajan i̇çeren kombi̇nasyonlar
JP2020096470A5 (tr)
CL2022001361A1 (es) Composiciones antimicrobianas que comprenden arcilla modificada y copolímeros.
MA54222A (fr) Combinaison d'un inhibiteur de mcl-1 et de midostaurine, utilisations et compositions pharmaceutiques associées
PE20200749A1 (es) Moduladores de la expresion de enac
TR201819202A2 (tr) Bi̇r multi̇pl skleroz ajani ve en az bi̇r kas relaksan ajan i̇çeren bi̇r kombi̇nasyon
MA47198A (fr) Combinaison d'un inhibiteur de mcl-1 et d'un composé de taxane, ses utilisations et compositions pharmaceutiques la comprenant
TR201818864A2 (tr) Di̇meti̇l fumarat ve en az bi̇r anti̇-epi̇lepti̇k ajan i̇çeren bi̇r kombi̇nasyon
MX2020013407A (es) Bio-herbicida a base de aceite esencial.
TR201818859A2 (tr) Di̇meti̇l fumarat ve en az bi̇r kas gevşeti̇ci̇ ajan i̇çeren bi̇r kombi̇nasyon
JP2020007767A5 (tr)
TR201721036A2 (tr) Flurbi̇profeni̇n modi̇fi̇ye salimli formülasyonlari
TR201910339T4 (tr) Mala.
PH12021550365A1 (en) Improving sleep or post-sleep performance
UA45416S (uk) 1. емблема «бурундук»
UA45414S (uk) 1. емблема «breik»
UA45415S (uk) 1. емблема «burunduk»
UA40287S (uk) Емблема «аrabica special»
UA45082S (uk) 1.-2. ювелірна прикраса - кольє «ile»
UA46507S (uk) 1. емблема «мегамайстер»